LATEST UPDATES
News & Notices
Follow our latest milestones, corporate announcements, and research progress in one place.
Pipeline
March 12, 2026QG3030 Advances Toward Phase 2 Readiness
Qgenetics has completed key preparation milestones to support the next clinical stage of QG3030.
Corporate
March 1, 2026Corporate Briefing Channel in Preparation for Investors and Partners
Qgenetics is preparing a structured briefing channel to share company updates, pipeline direction, and collaboration information.
Platform
February 24, 2026AI-MSC Platform Update Highlights Translational Progress
The company has expanded platform validation work linking stem-cell differentiation control with disease-focused development.